GlassScriptPhysician profile
Heidi Zuber
NPI 1396102273
$1,457.27
in general payments reported to CMS, 2019-2025
17 companies · $28.07 in 2025
The $28.07 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $168 · 2022: $437 · 2023: $468 · 2024: $356 · 2025: $28.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $307.21 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $250.50 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $206.98 | 2021-2024 | Farxiga, Breztri |
| Amgen INC. | $187.31 | 2022-2024 | Evenity, Prolia |
| Abbvie INC. | $169.95 | 2022-2024 | |
| Axsome Therapeutics, INC. | $64.36 | 2024 | Auvelity |
| Inspire Medical Systems, INC. | $34.83 | 2024 | Inspire |
| Glaxosmithkline, LLC. | $34.63 | 2021-2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Novartis Pharmaceuticals Corporation | $32.87 | 2022 | |
| Lilly USA, LLC | $28.10 | 2022-2023 | Mounjaro |
| Merck Sharp & Dohme LLC | $27.95 | 2022-2024 | Vaxneuvance, Gardasil, Capvaxive |
| Pfizer INC. | $26.73 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $25.54 | 2023 | Rexulti |
| Exact Sciences Corporation | $19.49 | 2024 | Cologuard Collection Kit |
| Corium, LLC | $15.00 | 2023 | Azstarys |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $13.55 | 2025 | Nuzyra |
| Kowa Pharmaceuticals America, INC. | $12.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Zuber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.